Effector Therapeutics Company
eFFECTOR Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs known as selective translation regulator inhibitors (STRIs).
Investors
.png)
Technology:
Others
Industry:
Genomic and Epigenominc Instabillity
Headquarters:
United States
Founded Date:
2012
Employees Number:
11-50
Estimated Revenue:
$10M to $50M
Register and Claim Ownership